Chargement en cours...

Prostate Cancer: Update on Early Detection and New Biomarkers

Screening and early treatment of prostate cancer (PCa) has recently come under scrutiny due to the rates of overdiagnosis of low risk cancer. Randomized trials, including ERSPC and PLCO, have informed our understanding of the survival benefit provided by systematic PCa screening with serum prostate-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mo Med
Auteur principal: Grubb, Robert L.
Format: Artigo
Langue:Inglês
Publié: Journal of the Missouri State Medical Association 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6139871/
https://ncbi.nlm.nih.gov/pubmed/30228704
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!